Nalo Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Nalo Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer (NCT05514496) | Nalo Therapeutics Inc. | 2022-10-05 |
Track Nalo Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.